Skip to Content

Archive: July 2025


Vendors

Resmed reports ‘strong finish’

July 31, 2025HME News Staff

SAN DIEGO – Resmed reported revenue growth of 10% to $1.3 billion for the fourth quarter of fiscal year 2025 compared to the same period the previous year. The company reported revenue growth of 10% to $5.1 billion for the full year 2025 compared to the previous year. “Our strong finish to fiscal year 2025 reflects ongoing momentum across our business, driven by robust global demand for our market-leading sleep and breathing health devices, as well as our expanding digital health...

2025, CPAP Therapy, fourth quarter, ResMed


Read Full Articlered right arrow icon

News

VGM launches advocacy toolkit

July 31, 2025HME News Staff

WATERLOO, Iowa – The VGM Government Relations team has launched a Grassroots Advocacy Toolkit to support durable medical equipment professionals, caregivers, industry partners and patient advocates in advancing legislative initiatives that impact equipment and services.   The toolkit includes materials and resources to assist in advocating for the DME industry, including:   Issue briefs: Clear, concise issue briefs outlining key legislative priorities and how...

Advocacy, Home Medical Equipment (HME), toolkit, VGM


Read Full Articlered right arrow icon

RFK

News

White House, tech leaders commit to rebuilding health care system

July 31, 2025HME News Staff

WASHINGTON – The White House and CMS have secured commitments from major health care and information technology firms – including Amazon, Anthropic, Apple, Google and OpenAI – to begin laying the foundation for a next-generation digital health ecosystem that they say will improve patient outcomes, reduce provider burden and drive value.  “For decades, bureaucrats and entrenched interests buried health data and blocked patients from taking control of their health,”...

Amazon, Apple, CMS, Google, health care technology, OpenAI, White House


Read Full Articlered right arrow icon

News

Dexcom grows 15% YOY, taps new CEO

July 31, 2025HME News Staff

SAN DIEGO - Dexcom reported revenue growth of 15% year-over-year to $1.157 billion for the second quarter of 2025.   Of that, U.S. revenue grew 15% and international revenue grew 16% on a reported basis year-over-year.  “During the quarter, Dexcom delivered strong revenue results, presented compelling clinical data at ADA, and further advocated for expanded coverage in key growth markets,” said Kevin Sayer, chairman and CEO. “In the second half of 2025, we look...

Read Full Articlered right arrow icon

News

AMA: PBM markets are at risk of harming patients

July 31, 2025HME News Staff

CHICAGO – Pharmacy benefit managers had little competition in 2023, with just four firms having two-thirds share of the national market, according to a new annual analysis published by the American Medical Association (AMA).  The analysis, based on 2022 and 2023 data on prescription drug plan (PDP) enrollees, measures competition in PBM markets and vertical integration of insurers with PBMs. The assessment demonstrates low competition in PBM markets across the nation and high vertical...

American Medical Association (AMA), Pharmacy Benefit Managers (PBMs)


Read Full Articlered right arrow icon

Ashlie White

Also Noted

White returns to AOPA

July 31, 2025HME News Staff

ALEXANDRIA, Va. – The American Orthotic and Prosthetic Association (AOPA) has announced that Ashlie White will join the organization as its new senior director of external affairs on Aug. 18. A nationally respected leader in orthotics and prosthetics (O&P) advocacy, health policy and strategic programming, White brings a wealth of experience and passion for improving both the O&P profession and the lives of individuals with limb loss and limb difference, AOPA says. “As AOPA doubles down...

American Orthotic & Prosthetic Assoc (AOPA), Ashlie White


Read Full Articlered right arrow icon

Also Noted

Humotech, Bio-Connect partner to expand access in Europe

July 31, 2025HME News Staff

PITTSBURGH, Pa. — Humotech, a U.S.-based company that specializes in prosthetics, exoskeletons and wearable robotics, has announced a strategic sales and distribution partnership with Bio-Connect BV, a Netherlands-based biomedical distributor. This collaboration will streamline purchasing and delivery across Europe by leveraging Bio-Connect’s regional expertise to support sales, contracting, fulfillment and logistics for Humotech’s Caplex System, Open Source Leg and other advanced...

Bio-Connect, Exoskeleton, Humotech, Prosthetics


Read Full Articlered right arrow icon

Also Noted

Inogen makes executive appointment

July 30, 2025HME News Staff

GOLETA, Calif. – Inogen’s board of directors has designated Jennifer Yi Boyer, executive vice president, enterprise enablement and chief human resources officer, as an “executive officer” of the company effective July 28, according to a Form 8-K filing. Yi Boyer has 29 years of strategic and transformational leadership experience. She joined Inogen in February 2022 as chief human resources officer and has risen internally to her current role. Prior to joining Inogen, she served...

Home Oxygen Equipment, Inogen


Read Full Articlered right arrow icon

Also Noted

NikoHealth adds integration expert

July 30, 2025HME News Staff

MIDDLETOWN TOWNSHIP, N.J. - NikoHealth has welcomed Alan Erceg to its team as principal solutions consultant. He brings more than a decade of experience in the health care technology space, including more than 10 years at Philips, where he specialized in API integrations, technical support and data connectivity. “We are excited to welcome Alan to the team as we continue to scale and elevate the customer experience,” the company stated in a LinkedIn post. As principal solutions consultant,...

Alan Erceg, NikoHealth


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care is ‘resilient’ in Q2, CEO says

July 30, 2025HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of about $1.416 billion for the second quarter of 2025, an increase of 15.4% over the same period in 2024. Gross profit was $269 million, or 19% of net revenue, up 7.9%.  Net income was $50.5 million vs. $53 million.  “I am proud of the second quarter performance and the Option Care Health team's ability to show resilience in a dynamic marketplace,” said John Rademacher, CEO. “We continue to execute...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon